Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Botulinum toxin A helped stop hair loss and grow new hair in mice.

A girl with no hair neglect developed plica neuropathica in the hospital, lost all her hair, but it grew back.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Baricitinib may effectively treat oral lichen planus.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Prolactin may be important for skin growth and immune function.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.